Dynavax and Mount Sinai Announce Collaboration to Develop a Universal Influenza Vaccine Candidate with CpG 1018 Adjuvant

NEXT STORY
VeeMed and Intel Collaborate to Launch Acute-care Telehealth Solution in All Banner Health Hospital COVID-19 Units
PREV STORY
Chiesi publishes its annual report: Group generates almost €2 billion and obtains B Corp certification in 2019
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Helsinn and MEI Pharma Announce Publication of Phase II Data for Pracinostat in Combination with Azacitidine in Blood Advances

Helsinn and MEI Pharma Announce Publication of Phase II Data for Pracinostat in Combination ...

author_avatar
NASDAQ Market News

FDA accepts Roche’s Biologics License Application for fixed-dose subcutaneous combination of Perjeta and Herceptin for HER2-positive breast cancer

author_avatar
NASDAQ Market News

Decisions taken by Orion Corporation’s Annual General Meeting on 25 March 2021

author_avatar
NASDAQ Market News